Tomoya Sano

471 total citations
35 papers, 250 citations indexed

About

Tomoya Sano is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomoya Sano has authored 35 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 15 papers in Epidemiology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomoya Sano's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (8 papers) and Liver Diseases and Immunity (5 papers). Tomoya Sano is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (8 papers) and Liver Diseases and Immunity (5 papers). Tomoya Sano collaborates with scholars based in Japan, United Kingdom and United States. Tomoya Sano's co-authors include Yuriko Tanaka, Noriho Kamiya, Yasushi Tanaka, Takuji Torimura, Takumi Kawaguchi, Masahiro Kobayashi, Hitomi Sezaki, Kenji Ikeda, Shunichiro Fujiyama and Yoshiyuki Suzuki and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Nutrients.

In The Last Decade

Tomoya Sano

27 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoya Sano Japan 9 95 85 50 47 39 35 250
Durgesh Dubey India 9 15 0.2× 55 0.6× 38 0.8× 163 3.5× 23 0.6× 17 325
Laura Nichols United States 9 35 0.4× 25 0.3× 3 0.1× 38 0.8× 81 2.1× 19 319
Xuefeng Ma China 13 76 0.8× 213 2.5× 3 0.1× 152 3.2× 40 1.0× 21 490
W.Y. Koh Singapore 5 23 0.2× 78 0.9× 2 0.0× 75 1.6× 120 3.1× 12 325
Xiaojiao Li China 9 16 0.2× 6 0.1× 9 0.2× 46 1.0× 44 1.1× 32 257
Yuhua Wen China 10 109 1.1× 45 0.5× 63 1.3× 37 0.9× 19 275
Masaru Fukahori Japan 11 20 0.2× 20 0.2× 3 0.1× 102 2.2× 95 2.4× 41 366
Zhongping Duan China 10 61 0.6× 88 1.0× 64 1.4× 23 0.6× 28 222

Countries citing papers authored by Tomoya Sano

Since Specialization
Citations

This map shows the geographic impact of Tomoya Sano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoya Sano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoya Sano more than expected).

Fields of papers citing papers by Tomoya Sano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoya Sano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoya Sano. The network helps show where Tomoya Sano may publish in the future.

Co-authorship network of co-authors of Tomoya Sano

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoya Sano. A scholar is included among the top collaborators of Tomoya Sano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoya Sano. Tomoya Sano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sano, Tomoya, et al.. (2025). FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities. International Journal of Molecular Sciences. 26(21). 10777–10777.
3.
Nakano, Masahito, Dan Nakano, Tomoya Sano, et al.. (2025). Regional Difference of Liver Cancer in Japan: A Real-world Evidence Using the National Database of Health Insurance Claims. Internal Medicine. 64(15). 2263–2269.
4.
Sano, Tomoya, et al.. (2025). Beyond Biomarkers: Machine Learning-Driven Multiomics for Personalized Medicine in Gastric Cancer. Journal of Personalized Medicine. 15(5). 166–166. 4 indexed citations
5.
Sano, Tomoya, Tatsuya Ide, Dan Nakano, et al.. (2025). The Effect of MAFLD on Hepatocarcinogenesis in HBeAg-negative Patients with Undetectable HBV-DNA under NA Therapy: A Multicenter Study. Internal Medicine. 64(8). 1133–1141.
6.
Sano, Tomoya, Takashi Sakuma, Yurie Yamamoto, et al.. (2024). Significance of Multi-Cancer Genome Profiling Testing for Breast Cancer: A Retrospective Analysis of 3326 Cases from Japan’s National Database. Genes. 15(6). 792–792. 1 indexed citations
7.
Sano, Tomoya, Masatsune Shibutani, Kenji Kuroda, et al.. (2024). [A Case of Postoperative Recurrence of Sigmoid Colon Cancer That Was Diagnosed as a Result of Cervical and Mediastinal Lymph Node Metastasis].. PubMed. 51(13). 1489–1491.
8.
Sano, Tomoya, et al.. (2024). Alpha-fetoprotein-producing intramucosal gastric cancer found during examination of metastatic lymph nodes. Clinical Journal of Gastroenterology. 18(1). 57–61.
9.
Suzuki, Hiroyuki, Kanji Yamaguchi, Tomoya Sano, et al.. (2024). Histological Improvement of Hepatic Fibrosis of Decompensated Liver Cirrhosis after Prednisolone and Azathioprine Treatment in a Patient with Autoimmune Hepatitis. The Kurume Medical Journal. 71(1.2). 69–74.
10.
Tsutsumi, Tsubasa, et al.. (2023). The Inter-Organ Crosstalk Reveals an Inevitable Link between MAFLD and Extrahepatic Diseases. Nutrients. 15(5). 1123–1123. 13 indexed citations
11.
12.
Arinaga‐Hino, Teruko, Tatsuya Ide, Jun Akiba, et al.. (2022). Growth differentiation factor 15 as a novel diagnostic and therapeutic marker for autoimmune hepatitis. Scientific Reports. 12(1). 8759–8759. 8 indexed citations
13.
Suzuki, Hiroyuki, Teruko Arinaga‐Hino, Tomoya Sano, et al.. (2022). Case Report: A Rare Case of Benign Recurrent Intrahepatic Cholestasis-Type 1 With a Novel Heterozygous Pathogenic Variant of ATP8B1. Frontiers in Medicine. 9. 891659–891659. 5 indexed citations
14.
Sano, Tomoya, Takumi Kawaguchi, Tatsuya Ide, et al.. (2021). Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B. Life. 11(3). 263–263. 5 indexed citations
15.
Kawamura, Yusuke, Masahiro Kobayashi, Junichi Shindoh, et al.. (2020). Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis. Liver Cancer. 9(3). 275–292. 31 indexed citations
16.
Arinaga‐Hino, Teruko, Mitsuhiko Abe, Tomoya Sano, et al.. (2020). Prednisolone-responsive primary sclerosing cholangitis with autoimmune hemolytic anemia: a case report and review of the literature. Clinical Journal of Gastroenterology. 14(1). 330–335. 4 indexed citations
17.
Kawamura, Yusuke, Masahiro Kobayashi, Junichi Shindoh, et al.. (2019). <sup>18</sup>F-Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma as a Useful Predictor of an Extremely Rapid Response to Lenvatinib. Liver Cancer. 9(1). 84–92. 21 indexed citations
18.
Arinaga‐Hino, Teruko, Hironori Koga, Jun Akiba, et al.. (2018). Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter‐3 in immunoglobulin G4‐related autoimmune hepatitis. Hepatology Research. 48(11). 937–944. 6 indexed citations
19.
Sano, Tomoya & Yuriko Tanaka. (1987). Effect of dried, powdered Chlorella vulgaris on experimental atherosclerosis and alimentary hypercholesterolemia in cholesterol-fed rabbits.. PubMed. 14(2). 76–84. 41 indexed citations
20.
Sano, Tomoya, et al.. (1972). Clinical significance of 1 -antitrypsin level--a preliminary evaluation among Japanese men.. PubMed. 31(1). 27–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Durgesh Dubey Breakdown of academic impact, for papers by Laura Nichols Breakdown of academic impact, for papers by Xuefeng Ma Breakdown of academic impact, for papers by W.Y. Koh Breakdown of academic impact, for papers by Xiaojiao Li Breakdown of academic impact, for papers by Yuhua Wen Breakdown of academic impact, for papers by Masaru Fukahori Breakdown of academic impact, for papers by Zhongping Duan
Rankless by CCL
2026